![]() |
Technical Data |
|
T8251-02 |
Transforming Growth Factor beta-2, Recombinant Human (TGFB2, BSC-1 Cell Growth Inhibitor, Cetermin, Glioblastoma-derived T-cell Suppressor Factor, G-TSF, MGC116892, Polyergin, TGF-beta2, TGF-beta-2) |
5ug |
| Growth Factors, Cytokines | Storage: -70°CShipping: Blue Ice |
|
Human Transforming Growth Factor beta2 (TGF- beta2) is stimulatory for cells of mesenchymal origin and inhibitory for cells of epithelial or neuroectodermal origin. Mature TGF- beta2 is a disulfide-linked homodimer of two chains composed of 112 aa residues each. There is a 70% homology between human TGF- beta2 and human TGF- beta1. Source: bacteria Biological Activity: The biological activity of human TGF- beta2 is determined by measuring the acidification of the culture medium (Rat-1 cells) exposed to the growth factor. Storage and Stability: Lyophilized powder may be stored at -20°C. Reconstitute to with sterile dH2O or buffer, aliquot and store at -20°C. Reconstituted product is stable for 6 months at -20°C. For maximum recovery of product, centrifuge the original vial after thawing and prior to removing the cap. Further dilutions can be made in assay buffer. Molecular Weight: 25kD |
Source: bacteria Purity: Purified. 98% pure by non-reduced SDS gel electrophoresis. Concentration: As reported Form: Supplied as a lyophilized powder in PBS, pH 2.5. Important Note: This product as supplied is intended for research use only, not for use in human, therapeutic or diagnostic applications without the expressed written authorization of United States Biological. |
|
1. Moustakas, A., Lin, H.Y., Henis, Y.I., Plamondon, J., O'Conner-McCourt, M.D., and Lodish, H.F., (1993) The Journal of Biological Chemistry, Vol 268, 30, October, 22215-22218. 2. Geiser, A.G., Burmester, J.K., Webbink, R., Roberts, A.B., and Sporn, M.B., (1992). The Journal of Biological Chemistry, Vol 267, 4, February, 2588-2593.
|
||